Pulmonology (Sep 2022)

Dilation with rigid dilators as primary treatment of subglottic stenosis in pediatrics

  • E.J. Romero Manteola,
  • C. Patiño González,
  • P. Ravetta,
  • V. Defago,
  • C. Tessi

DOI
https://doi.org/10.1016/j.pulmoe.2020.03.007
Journal volume & issue
Vol. 28, no. 5
pp. 345 – 349

Abstract

Read online

Introduction Acquired subglottic stenosis (SGS) occurs in 1–2% of children with a history of intubation. An alternative treatment is endoscopic dilation with rigid dilators.Material and methods Seventy-four patients with SGS grade I to III were treated between 2003 and 2017. Dilations were performed with Hegar-type rigid dilators every 2–3 weeks.Results Eighty-two percentage of patients responded to the treatment. 10% presented SGS grade I, 35% grade II and 55% grade III. Previous intubation time in successful cases was 12.4 days and it was 32 days in those that failed (p = 0.02). The average number of dilations was 3.23 in the group that responded and 2.98 for those that did not respond (p = 0.51). The presence of tracheostomy reduced the effectiveness of the treatment (p = 0.002). The average follow-up was 43.5 months.Conclusion The use of rigid dilators under endoscopic control is an effective minimally invasive method for treating patients with SGS grades I to III. Previous intubation time and the presence of tracheostomy were identified as poor prognostic factors.

Keywords